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INTRODUCTION
Mycobacterium kansasii is a slow growing photochromogen,
usually isolated from various water sources (1-4). M. kansasii
is the second most commonly isolated  nontuberculous myco-
bacteria (NTM) after M. avium-intracellulare in the United Sta-
tes and Japan (5-8). Furthermore, it is the most common NTM
in some areas (9, 10).
The incidence or detection of the disease caused by NTM
usually increases with decreasing the prevalence of tuberculo-
sis (TB). Although the prevalence of active TB has dramatical-
ly decreased from 5.1% in 1965 to 0.5% in 2002 (11) dur-
ing the past 40 yr in Korea, there has been no recent report
on the change of the annual numbers of NTM isolation in-
cluding M. kansasii. In this study, we evaluated changes in
the number of M. kansasii isolation and examined the clinical
characteristics of patients with pulmonary disease due to M.
kansasii in Korea. 
MATERIALS AND METHODS
Isolation of M. kansasii
To determine the annual number of isolation of M. kansasii
in clinical samples, we searched the database of the Korean
Institute of Tuberculosis, the referral tuberculosis laboratory.
The identification of individual NTM has only been possible
because the Korean Institute of Tuberculosis started to identi-
fy individual species of NTM through 1992 to 2002; thus we
searched the database from 1992 to 2002 and collected data
on the annual isolations of the each species of NTM including
M. kansasii. During the period from 1992 to 2000, mycobac-
terial species identifications were performed by the traditional
biochemical method (12). From January 2001, the species
identification of mycobacteria was performed by the PCR-res-
triction fragment length polymorphism (RFLP) of the poly-
morphic region of the rpoB gene (13).
M. kansasii pulmonary disease
We identified patients from whom M. kansasii was isolat-
ed from January 1997 to December 2002. Among these, pa-
tients with a M. kansasii positive culture on 2 or more times
were defined to have a M. kansasii pulmonary disease as sug-
gested before (9). A questionnaire was sent to the responsible
physicians, which requested details on; demographic patient
characteristics, symptoms, signs, laboratory findings, radio-
graphic findings, treatment regimen, and treatment response.
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Mycobacterium kansasii Pulmonary Diseases in Korea
Mycobacterium kansasii is one of the most common cause of pulmonary diseases
due to nontuberculous mycobacteria. We investigated the changing in the number
of isolation of M. kansasii and the clinical characteristics of M. kansasii pulmonary
disease in Korea. Through searching the database of the Korean Institute of Tuber-
culosis, we identified the cases of isolated M. kansasii from 1992 to 2002. The num-
ber of M. kansasii isolation had increased from once in 1992 to 62 in 2002. Fifteen
patients with M. kansasii pulmonary disease were identified during the period Jan-
uary 1997 to December 2002. Twelve patients (80%) were male and fourteen (93%)
were from highly industrialized areas. The most common symptom was a cough.
Seven patients (47%) had a cavitary lesion and right upper lobe was most common-
ly involved. Patients responded well to isoniazid and rifampicin based regimens both
bacteriologically and radiographically. In conclusion, M. kansasii isolation has in-
creased, especially in highly industrialized areas, as well as other nontuberculous
mycobacteria in Korea.
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Accepted : 13 June 2005Patients with positive M. tuberculosis culture in the same
period, incomplete clinical record were excluded for the anal-
ysis, and patients with no response to isoniazid and rifampi-
cin-based chemotherapies were also excluded, because we
wanted to exclude those NTM simply colonized in their lungs
with previous tuberculosis sequelae.
RESULTS
The number of isolation of M. kansasii and other NTM
The total number of mycobacterial colonies referred to Kore-
an Institute of Tuberculosis for identification decreased from
18,970 in 1992 to 5,181 in 2002. In 1992, M. kansasii was
identified once (0.2%) from among 448 NTM, and this in-
creased to 62 times (3.6% out of 1,737 colonies) in 2002. Dur-
ing the same period, the number of NTM detections increased
from 448 to 1,737. M. avium-intracellulare was found to be the
most common through 1992 to 2002, and showed an increas-
ing tendency. M. fortuitum, M. absessus and M. gordonae were
also found to increase.
M. kansasii pulmonary diseases
During the period January 1997 to December 2002, M.
kansasii was isolated 204 times from 150 patients. Among
these, the number of patients positive for M. kansasii by cul-
ture 2 or more times was 30. Among these 30 patients, we
excluded 7 from analysis because of insufficient clinical data
and another 2 due to a positive M. tuberculosis culture in same
period. Of the other 21 patients, 6 patients were excluded
because their pulmonary lesion in chest radiographs did not
improve after at least 6 months of isoniazid and rifampicin-
based treatment. Even though M. kansasii was isolated more
than twice from the sputum of these 6 patients, we decided
that in these patients M. kansasii might be a colonizer rather
than a true pathogen.
Among the 150 patients positive for M. kansasii, 76 (51%)
lived in Seoul, the largest city in Korea (Fig. 1A). Other highly
industrial cities such as, Ulsan (18 patients, 12%), Busan (16
patients, 11%) and Incheon (16 patients, 11%) were also rep-
resented. The other patients came also from highly industri-
alized areas or large cities, only 4 patients lived in rural areas.
Fourteen of 15 patients with M. kansasii pulmonary disease
were from highly industrialized cities (Fig. 1B). 
The median age of the 15 patients with M. kansasii pulmo-
nary disease was 41 yr (range; 26-70) and 12 were men (Table
1). 75% of them were current or ex-smokers and 9 (60%) had
a history of previous tuberculosis. Two patients had been diag-
nosed as having bronchiectasis. Their most common symp-
tom was a cough, of which eight (53%) patients complained;
hemoptysis, dyspnea, and fatigue followed. Seven (47%) of
15 patients had cavitary lesions in chest radiographs, 7 pa-
tients had nodulostreaky lesions and 1 had consolidation with-
out a cavity. The most frequently involved lung site was the
right upper lobe, 52% of all described lesion was found in the
right upper lobe. 
A combination of isoniazid, rifampicin, pyrazinamide and
ethambutol were prescribed initially for 11 patients, and
streptomycin was used in combination with these for another
1 patient. Rifampicin, cycloserine, prothionamide and ofloxa-
cin were prescribed initially in one, rifampicin, pyrazinamide,
ethambutol and ofloxacin in another, and rifampicin, pyrazi-
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Fig. 1. Geographic distribution of patients with a M. kansasii positive culture (A) and probable M. kansasii pulmonary disease (B). Patients
not matched with a city were from rural areas.
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1namide, cycloserine, and prothionamide in the remaining
patient. The median duration of treatment was 10.5 months,
3 patients experienced hepatotoxicity, and one of these was
moved on to other regimen. Three patients experienced myal-
gia, pruritus or gastrointestinal disturbance, respectively. In
10 of 15 patients with M. kansasii pulmonary diseases, a fol-
low-up mycobacterial culture was performed. Negative con-
version of the mycobacterial culture was observed in all 10
patients at 4.0 months (median). In another 3 patients, only
follow-up AFB smears were performed, and smear conversion
was reported in all 3 at 2.0 months (median) after the initia-
tion of treatment. Neither a subsequent AFB smear nor a
culture was performed in the other 2 patients.
Complete resolution of the radiographic lesion was observed
in 2 patients, one of these had a cavitary lesion, and the other
had a nodulo-streaky lesion. The other 13 patients experienced
definite radiographic improvement, but incomplete resolution.
DISCUSSION
M. kansasii is a slow growing photochromogen, which grows
over a temperature range from 32 to 42℃. The biochemical
identification of M. kansasii has been based on its ability to
produce catalase and nitrate reductase, and to hydrolyze Tween
80 (14). M. kansasii has been recovered from water sources.
Drinking water distribution systems, tap water and shower
heads has been reported to be sources of M. kansasii (1-4).
These reports of M. kansasii isolations from water distribution
systems, and the fact that this organism can survive in water
for up to 12 months (15) support the hypothesis that infection
by M. kansasii occurs via an aerosol route (16).
Our results show that the number of isolation of NTM in-
creased from 448 in 1992 to 1,562 in 2002, while the preva-
lence of active TB over the same period decreased from 1.8%
to 0.5% (11). This increase could be due, more probably, to
the advances in laboratory methodology and physicians’ con-
cern for NTM rather than the decreased prevalence of tuber-
culosis. In addition, the number of isolation of NTM could
be biased because not all mycobacterial colonies isolated had
been requested to Korean Institute of Tuberculosis. However,
the fact that the total number of mycobacterial colonies re-
quested for identification decreased from 18,970 in 1992 to
5,181 in 2002 suggests the possibility of real increase of NTM
prevalence in Korea. 
Pulmonary disease caused by M. kansasii is known to be
more common in urban areas than in rural areas (10, 17), whi-
ch concurs with our findings. The Korean patients with M.
kansasii in the lung, regardless as to whether it was as a pa-
thogen or as a colonizer, were predominantly living in high-
ly industrialized cities. Half of the patients with M. kansasii
lived in Seoul, the largest Korean city of over 10 million peo-
ple, the next most common location was Ulsan, which is the
7th largest city in Korea, but is heavily industrialized. Other
cities represented were Incheon and Busan, which are also
highly industrialized. In contrast, few patients were found to
be domiciled in the cities of south-west and north-east region
of Korea, where agriculture remains the main occupation. This
distribution is in accord with a Japanese observation published
in 1983 (18) and a study, which reported that 56% of patients
with M. kansasii pulmonary disease were employed in heavy
industry (19).
The clinical characteristics of M. kansasii pulmonary disease
patients in the present study were similar to those of previous
reports including Korean cases (10, 19, 20). Thus, the present
study confirms an association between M. kansasii pulmonary
disease with, a male gender, an urban setting, a history of tu-
berculosis or of another lung disease as a risk factor, a cough
as a common symptom, the presence of a cavitary lesion usu-
ally in the right upper lobe, and a response to an isoniazid
M. kansasii Pulmonary Diseases in Korea 959
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
M. kansasii 1 9 21 18 16 12 22 26 35 47 62
M. avium-intracellulare 245 302 329 287 266 253 551 499 593 693 769
M. fortuitum 49 66 60 41 27 20 47 62 56 92 184
M. chelonae complex 32 34 43 55 23 28 63 92 88 166 279
M. chelonae n-a n-a n-a n-a n-a n-a n-a n-a n-a 8 18
M. absessus n-a n-a n-a n-a n-a n-a n-a n-a n-a 158 261
M. scrofulaceum 13 1 523 04000 2
M. terrae complex 14 25 43 27 8 5 32 25 35 3 52
M. szulgai 32950 66 1 3 1 8 1 2 1 5
M. gordonae 5 12 21 10 15 9 22 39 18 31 126
M. celatum 0 0 0 0 0 0 12 8 11 7 10
M. marinum 00000 21011 0
M. smegmatis 00000 00000 0
Unidentifiable 98 250 608 403 558 752 422 400 314 559 63
Total 448 791 1,149 848 916 1,087 1,182 1,164 1,169 1,611 1,737
Table 1. The number of NTM isolates from clinical specimens requested for the identification to the Korean Institute for Tuberculosis,
1992-2002
*n-a, non-applicable.
year
Organismand rifampicin based regimen 
In conclusion, the number of M. kansasii isolation seems
to be increasing in Korea. Most of the patients were domi-
ciled in industrialized urban communities, and the clinical
characteristics of the patients were similar to those reported
previously.
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